Arm 2: Clinical Trials

29 trials of Arm 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 4 not yet recruiting, 4 recruiting, 4 unknown. 14 Not applicable, 9 Phase 2, 3 Phase 3, 2 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable14Completed 9, Recruiting 2, Unknown 2, Not yet recruiting 1
Phase 29Completed 4, Not yet recruiting 2, Unknown 2, Recruiting 1
Phase 33Completed 3
Phase 12Terminated 1, Unknown 1
Phase 41Not yet recruiting 1

Follow Arm 2: new trials by email Literature Review of Arm 2 trials Research Report on Arm 2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer
Arm1, Arm 2, Arm 3 - CRC (Colorectal Cancer), BRAF
Phase 2Not yet recruitingSun Yat-sen University912026-11-302026-07-21
Pain Science Education and Therapeutic Exercise in Adults With Musculoskeletal Pain
Pain Neuroscience Education (PNE) + Therapeutic Exercise, Therapeutic Exercise - Chronic Musculoskeletal Pain
Not applicableCompletedUniversity of Vigo382026-05-012026-08-26
Effects of Resistance-based Exercise Snacks With Varying Fragmentation Patterns on Lower Limb Function and Executive Cognition in Pre-frail Older Adults
Highly Fragmented Exercise Snack, Moderately Fragmented Exercise Snack, Lowly Fragmented Exercise Snack - Effects of Exercise on Older Adults
Not applicableNot yet recruitingCapital University of Physical Education and Sports, China602026-05-012026-04-24
Clinical Study of a Facial Cream for Rosacea
ARM 1, ARM 2 - Facial Rosacea
Not applicableRecruitingChinaNorm762026-04-282026-06-09
GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries
Volume Modulated Arc Therapy (VMAT), Intensity Modulated Proton Therapy (IMPT) - Gynaecologic Cancer, Cervical Cancer
Phase 2RecruitingUniversity of Maryland, Baltimore1162026-03-252026-08-10
Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Tunlametinib + Cetuximab β, Tunlametinib + Fulzerasib - Lung Cancer (NSCLC)
Phase 2Not yet recruitingSun Yat-sen University552026-03-152026-03-11
Fractionated Spinal Anesthesia With Combined Isobaric and Hyperbaric Bupivacaine for Elderly Hip Fracture Patients
Fractionated SA with isobaric and hyperbaric bupivacaine, Fractionated SA with hyperbaric bupivacaine, Conventional SA group - Spinal Anesthesia in Elderly Patients
Not applicableCompletedTanta University1082025-12-202026-07-31
Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation
arm 2, arm 1 - Uterine Fibroids (UF)
Phase 4Not yet recruitingKaohsiung Medical University602024-10-012024-10-15
A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates
Arm1, Arm 2 - Ulcerative Colitis
Phase 2CompletedZydus Lifesciences Limited242024-04-082024-12-20
Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Valacyclovir celecoxib dose 1, Valacyclovir celecoxib dose 2, Placebo - Long COVID, PASC Post Acute Sequelae of COVID 19
Phase 2CompletedBateman Horne Center592023-10-152025-01-22
Maternal Mental Health Access - MaMa
Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention, On-Demand + Discussion board (DB), Arm 2 - Postpartum Depression, Perinatal Depression
Not applicableRecruitingUniversity of Utah1202023-04-042024-12-06
tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)
Arm 1, Arm 2, Arm 3 - Nasopharyngeal Carcinoma
RecruitingNational Cancer Centre, Singapore10002022-11-172024-09-19
Brighter Bites & UT Physicians Produce Rx Program
Arm 1, Arm 2, Arm 3 - Obesity, Childhood
Not applicableCompletedThe University of Texas Health Science Center, Houston1502022-10-172024-12-06
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
No stress testing, stress testing - Coronary Artery Disease, Percutaneous Coronary Intervention
Not applicableUnknownAssistance Publique - Hôpitaux de Paris26642021-09-302024-06-03
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
Chloroprocaine 3%, Tetracaine 0.5% - Cataract
Phase 3CompletedSintetica SA3382020-09-092023-01-18
Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients
Arm 1, Arm 2, Arm 3 - Hemiplegia And/or Hemiparesis Following Stroke
Not applicableCompletedHôpital NOVO242020-08-282024-09-19
The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population
Chloroprocaine 1% Injectable Solution, Chloroprocaine 2% Injectable Solution - Hernia, Inguinal, Flat Foot
Phase 2CompletedSintetica SA1642019-02-142026-03-23
Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
arm 0, arm 1, arm 2 - Gout
Phase 2CompletedJW Pharmaceutical1712019-01-212021-03-18
Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study
Paraspinal, Paraspinal EX, Paraspinal VR - Spinal Cord Injuries, Spinal Cord Compression
Not applicableUnknownMD Stem Cells402017-07-012024-04-16
Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study
Arm1, Arm 2, Arm 3 - Oral Squamous Cell Carcinoma, Carcinoma of Buccal Mucosa
Phase 2UnknownTata Memorial Hospital642015-08-182022-04-28

Showing 20 of 29. Sign in to see all of them.

Conditions studied

Colorectal Neoplasms (2)  ·  Head and Neck Neoplasms (2)  ·  Spinal Cord Injuries (2)  ·  Uterine Cervical Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Squamous Cell (1)  ·  Cataract (1)  ·  Chronic Pain (1)  ·  Colitis, Ulcerative (1)  ·  Coronary Artery Disease (1)  ·  Depression (1)  ·  Depression, Postpartum (1)  ·  Flatfoot (1)  ·  Glaucoma, Open-Angle (1)  ·  Gout (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  Sintetica SA (2)  ·  Sun Yat-sen University (2)  ·  VA Office of Research and Development (2)  ·  All India Institute of Medical Sciences (1)  ·  Amgen (1)  ·  Bateman Horne Center (1)  ·  Capital University of Physical Education and Sports, China (1)  ·  ChinaNorm (1)  ·  Daniel Moore (1)  ·  Hôpital NOVO (1)  ·  JW Pharmaceutical (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Kaohsiung Medical University (1)  ·  MD Stem Cells (1)

Countries

United States (10)  ·  China (3)  ·  France (3)  ·  India (3)  ·  Spain (3)  ·  Italy (2)  ·  Egypt (1)  ·  Singapore (1)  ·  Slovakia (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

Annette E Maxwell, Dr.P.H. (1)  ·  Christine Markham, PhD (1)  ·  Daniel B. Moore, M.D. (1)  ·  Dr. Deven Parmar, MD,FCP (1)  ·  Elizabeth Nichols, MD (1)  ·  Gwen Latendresse (1)  ·  Jeffrey Weiss, MD (1)  ·  Jorge Alio, MD (1)  ·  Lisa Ottomanelli, PhD (1)  ·  Lucinda Bateman, MD (1)  ·  Melvin Lee Kiang Chua, MBBS, FRCR, PhD, FAMS (1)  ·  Nadine Pellegrini (1)  ·  Nadjib Hammoudi, MD PHD (1)

Results publications

PMID 17462120, PMID 18708385, PMID 20864724, PMID 21111754, PMID 22541306, PMID 23345022, PMID 23635998, PMID 24316325, PMID 24486426, PMID 24752942, PMID 24912059, PMID 25232517, PMID 25572620, PMID 25762858, PMID 25856266, PMID 31094800, PMID 35607733, PMID 35665737, PMID 38489057, PMID 40420308

NIH funding

R01CA127964 (1), RF1NR020841 (1)